Finding the right dose of a bleeding disorder medication

This trial is testing whether people with hemophilia A—a rare bleeding disorder—can do well on lower, personalized doses of emicizumab, a medication that helps prevent bleeding. Right now, everyone takes the same standard dose, but this study will check blood levels and adjust doses for each person to see if less medication still works just as well.

Emicizumab works very well to prevent dangerous bleeds in people with hemophilia A, but it is very expensive. This trial wants to see if using lower, customized doses can keep patients safe while reducing costs and making the medication available to more people who need it.